Science Explorer Back to mapMap
Discussion
Researcher · European Institute of Oncology · Italy

Pier Giuseppe Pelicci

Pier Giuseppe Pelicci publishes mostly in Molecular Biology, Hematology and Oncology, on topics such as Acute Myeloid Leukemia Research, Retinoids in leukemia and cellular processes and Cancer Genomics and Diagnostics.

ORCID 0000-0002-5076-2316 OpenAlex
World rank
#123,951
of 7,710,434 ranked researchers
Rank in Italy
#2,543
of 242,206
Works
951
Citations
66k
Citations per work
69.0
h-index
127
i10-index 481Top 0.1% in Molecular Biology
Pier Giuseppe Pelicci

What does Pier Giuseppe Pelicci research?

Pier Giuseppe Pelicci's work is mostly in Biochemistry, Genetics and Molecular Biology (41%), Medicine (22%), Immunology and Microbiology (6%).

Life Sciences: 441 works · 46.4% of their workBiochemistry, Genetics and Molecular Biology: 388 works · 40.8% of their workMolecular Biology: 340 works · 35.8% of their workCancer Research: 48 works · 5.0% of their workImmunology and Microbiology: 53 works · 5.6% of their workImmunology: 53 works · 5.6% of their workEverything else: 304 works · 32.0% of their workHealth Sciences: 205 works · 21.6% of their workMedicine: 205 works · 21.6% of their workHematology: 103 works · 10.8% of their workOncology: 80 works · 8.4% of their workGenetics: 23 works · 2.4% of their workTHEIR WORKPier GiuseppePelicci951works
Life Sciences46%Health Sciences22%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology38840.8%
    2. Immunology and Microbiology535.6%
  2. Everything else30432.0%
    1. Medicine20521.6%
  1. 1Molecular Biology36% of their works
  2. 2Hematology11% of their works
  3. 3Oncology8% of their works
  4. 4Immunology6% of their works
  5. 5Cancer Research5% of their works
  6. 6Genetics2% of their works

Research topics

Which keywords describe Pier Giuseppe Pelicci's research?

The keywords of their largest research topics: Acute Myeloid Leukemia, AML, Acute Promyelocytic Leukemia, Retinoic Acid, Cancer Genomics, Mutational Signatures, DNA Methylation and Histone Modification.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 16 words, with their numbers
  1. AML1771 topic
  2. Acute Myeloid Leukemia1771 topic
  3. Acute Promyelocytic Leukemia1551 topic
  4. Retinoic Acid1551 topic
  5. Cancer Genomics591 topic
  6. Mutational Signatures591 topic
  7. DNA Methylation581 topic
  8. Histone Modification581 topic
  9. Cell Cycle441 topic
  10. p53441 topic
  11. BET Bromodomains391 topic
  12. PROTACs391 topic
  13. Cancer Stem Cells381 topic
  14. Chromatin381 topic
  15. Transcription381 topic
  16. Tumor Metastasis381 topic

Where does Pier Giuseppe Pelicci work?

Pier Giuseppe Pelicci's main affiliation in the publication record is European Institute of Oncology, Italy.

How many publications and citations does Pier Giuseppe Pelicci have?

OpenAlex counts 951 works and 65,590 citations for Pier Giuseppe Pelicci, an h-index of 127, ranking #123,951 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Pier Giuseppe Pelicci. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.